Research programme: metabolic disorder therapeutics - 7TM Pharma/Dr. Reddy's Laboratories
Latest Information Update: 04 Nov 2017
Price :
$50 *
At a glance
- Originator 7TM Pharma; Dr Reddys Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Metabolic-disorders in USA
- 06 Jul 2010 This programme is still in active development
- 17 Mar 2008 Early research in Metabolic disorders in USA (unspecified route)